180
sticky is as sticky does
https://mjbizdaily.com/cannabis-strain-names-dont-mean-much-give-false-sense-of-diversity/
So some researchers tested thousands of samples of medical cannabis (obtained in NV), and they found a couple things:
1) despite the different names, most samples fell into three distinct groups in terms of cannabinoids and terpenes; there was not much diversity of chemical composition among the samples, just a lot of different names for very similar weed.
2) the market is still focused almost exclusively on THC levels; hardly anyone is working on other cannabinoids (except for CBD cultivars). So the medical effects of different cannabinoids are not being pursued by many growers.
What this says to me is that the market is still in its infancy. With more testing and more emphasis on a diversity of cannabinoids and terpenes, new uses for our favorite weed will be discovered/promoted. THCV, Delta-8 THC, CBG, CBN, etc.
So some researchers tested thousands of samples of medical cannabis (obtained in NV), and they found a couple things:
1) despite the different names, most samples fell into three distinct groups in terms of cannabinoids and terpenes; there was not much diversity of chemical composition among the samples, just a lot of different names for very similar weed.
2) the market is still focused almost exclusively on THC levels; hardly anyone is working on other cannabinoids (except for CBD cultivars). So the medical effects of different cannabinoids are not being pursued by many growers.
What this says to me is that the market is still in its infancy. With more testing and more emphasis on a diversity of cannabinoids and terpenes, new uses for our favorite weed will be discovered/promoted. THCV, Delta-8 THC, CBG, CBN, etc.